comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 19:01:41 - browse：837

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： 10 reasons why health care startups fail

entertainment

Wikipedia

WSS

Wegovy leads to weight loss. Can it treat depression, too?

Health Care Service Corp to buy Cigna Medicare Advantage plans

Second House panel advances two

FTC sues over Novant Health acquisition of two N.C. hospitals

Biogen walks away from Aduhelm, years after polarizing approval

NVIDIA and Google execs on the future of AI and drug discovery

Wikipedia

comprehensive

entertainment

In Memoriam: Notable people who died in 2023

How generative AI ratchets up security threats for health systems

In Memoriam: Notable people who died in 2023

Wegovy leads to weight loss. Can it treat depression, too?

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Affirmative action in medical school literally saved lives

Wegovy leads to weight loss. Can it treat depression, too?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

focus

How generative AI ratchets up security threats for health systems

Readers respond to H5N1 and livestock movements, and more

Merck, Johnson & Johnson CEOs will testify on high drug prices

Boston competes with Raleigh

Bernie Sanders is gearing up to subpoena pharma CEOs

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

entertainment

entertainment

Wikipedia

knowledge